We are live on
!
Find out more
CPI
Canaan Partners IX Portfolio holdings
AUM
$87.5M
This Fund
S&P 500
This Quarter
Est. Return
+53.42%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.6M
AUM Growth
+$23.2M
(+53%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CytomX Therapeutics
CTMX
$788M
| $66.6M | 100% |
4,244,381
| – | – |
|
Similar funds
HH
SLM
JAM
TIMH
TCM
CCFP
PC
BAM
Canaan Partners IX's Q3 2016 Portfolio in Review
As of Q3 2016, Canaan Partners IX held 1 position worth $66.6M, up 53% from $43.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2016: portfolio turnover was 0%. Canaan Partners IX opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Canaan Partners IX's ten largest holdings make up 100% of its $66.6M portfolio in Q3 2016.
- Canaan Partners IX opened 0 new positions and closed 0 in Q3 2016.
- Canaan Partners IX's portfolio value rose 53% quarter-over-quarter to $66.6M.
Based on Canaan Partners IX's 13F filing for Q3 2016, filed 7 Oct 2016.